These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1057462
21. Adjuvant chemotherapy for osteosarcoma: a decade of experience. Goorin AM, Frei E, Abelson HT. Surg Clin North Am; 1981 Dec; 61(6):1379-89. PubMed ID: 6976007 [No Abstract] [Full Text] [Related]
22. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies. Graham-Pole J, Ayass M, Cassano W, Dickson N, Enneking W, Heare M, Heare T, Marcus R, Saleh R, Spanier S. Cancer Treat Res; 1993 Dec; 62():339-46. PubMed ID: 8096749 [No Abstract] [Full Text] [Related]
23. Osteosarcoma--the winds of change. Mills EE. S Afr Med J; 1978 May 06; 53(18):695-8. PubMed ID: 308700 [Abstract] [Full Text] [Related]
24. [Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)]. Pontz BF, Gutjahr P. Dtsch Med Wochenschr; 1981 Feb 13; 106(7):200-7. PubMed ID: 6937343 [No Abstract] [Full Text] [Related]
25. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS). Winkler K, Bielack SS, Delling G, Jürgens H, Kotz R, Salzer-Kuntschik M. Cancer Treat Res; 1993 Feb 13; 62():269-77. PubMed ID: 7682088 [Abstract] [Full Text] [Related]
26. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C. Cancer; 1993 Dec 01; 72(11):3227-38. PubMed ID: 8242546 [Abstract] [Full Text] [Related]
27. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II. Jaffe N, Frei E, Traggis D, Cassady JR, Watts H, Filler RM. Cancer Treat Rep; 1977 Jul 01; 61(4):675-9. PubMed ID: 301780 [Abstract] [Full Text] [Related]
28. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. Bacci G, Gherlinzoni F, Picci P, Van Horn JR, Jaffe N, Guerra A, Ruggieri P, Biagini R, Capanna R, Toni A. Eur J Cancer Clin Oncol; 1986 Nov 01; 22(11):1337-45. PubMed ID: 3493903 [Abstract] [Full Text] [Related]
29. Osteosarcoma: review of the past, impact on the future. The American experience. Jaffe N. Cancer Treat Res; 2009 Nov 01; 152():239-62. PubMed ID: 20213394 [Abstract] [Full Text] [Related]
30. Adjuvant and neoadjuvant chemotherapy in osteosarcoma. Bacci G, Lari S. Chir Organi Mov; 2001 Nov 01; 86(4):253-68. PubMed ID: 12056242 [Abstract] [Full Text] [Related]
31. [Initial chemotherapy and conservative surgery in the current treatment of osteosarcoma. Apropos of 24 cases]. Brunat-Mentigny M, Blondet R, Bouffet E, Chauvot P, Moyen B, Philip T. Ann Pediatr (Paris); 1984 Oct 15; 31(9):773-8. PubMed ID: 6084439 [No Abstract] [Full Text] [Related]
33. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501 [Abstract] [Full Text] [Related]
34. Multiple-drug chemotherapy for the primary treatment of osteosarcoma of the extremities. Campanacci M, Bacci G, Pagani P, Giunti A. J Bone Joint Surg Br; 1980 Feb 01; 62-B(1):93-101. PubMed ID: 6927980 [Abstract] [Full Text] [Related]
35. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group. Recent Results Cancer Res; 1978 Feb 01; 68():28-32. PubMed ID: 288108 [No Abstract] [Full Text] [Related]
36. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients. Tunn PU, Reichardt P. Onkologie; 2007 May 01; 30(5):228-32. PubMed ID: 17460416 [Abstract] [Full Text] [Related]
37. Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy. Tefft M, Chabora BM, Rosen G. Cancer; 1977 Feb 01; 39(2 Suppl):806-16. PubMed ID: 402197 [Abstract] [Full Text] [Related]
38. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection. Berend KR, Pietrobon R, Moore JO, Dibernardo L, Harrelson JM, Scully SP. J Surg Oncol; 2001 Nov 01; 78(3):162-70. PubMed ID: 11745799 [Abstract] [Full Text] [Related]
39. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute. Bacci G, Picci P, Ferrari S, Avella M, Prever BA, Ruggieri P, Casadei R, Lari S, Monti C, Cazzola A. Cancer Treat Res; 1993 Nov 01; 62():299-308. PubMed ID: 7682090 [No Abstract] [Full Text] [Related]
40. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma]. Delépine N, Alkallaf S, Cornille H, Markowska B, Delépine G. Ann Med Interne (Paris); 2003 Feb 01; 154(1):12-24. PubMed ID: 12746655 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]